Related Experiment Video
Updated: Dec 26, 2025

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents
Published on: May 16, 2022
Effect of a Commercially Available Low-Dose Capsaicin Supplement on Knee Extensor Contractile Function
Brett L Cross1, Darell Parker1, Sean P Langan1
1Biodynamics and Human Performance Center, Georgia Southern University (Armstrong Campus), Savannah, GA, USA.
Abstract:
Capsaicin, the active pungent ingredient in chili peppers and various spicy foods, is demonstrated to influence a variety of physiological systems including skeletal muscle. The purpose of this study was to examine if a chewable capsaicin supplement (1.2 mg) could enhance isokinetic knee extensor contractile performance. Nine young, recreationally active individuals (5 females/4 males; 23.6 ± 1.5 yrs; 24.2 ± 3.3 kg/m2) participated in this randomized, single-blind crossover study. Following a familiarization session, participants completed two isokinetic knee extensor contractile function assessments, 45 minutes after ingesting either a capsaicin fruit gummy or eucaloric placebo, the order of which was randomized. Knee extensor peak torque (strength), summed torque (endurance) and fatigue index (fatigue) were compared between trials. Knee extensor peak torque was significantly greater (p < 0.05; d = 0.80) in the capsaicin (126.0 ± 40.4 N·m-1) than the placebo (118.8 ± 41.3 N·m-1) trial. No significant differences (p > 0.05) were found for summed torque (8012 ± 2771 vs. 7823 ± 2611 N·m-1; d = 0.45) or fatigue index (56.0 ± 17.1 vs. 48.7 ± 21.0 %; d = 0.46) between capsaicin and placebo trials, respectively. These findings, in a relatively modest and mixed-gender sample, suggest that pre-exercise capsaicin ingestion may benefit knee extensor muscle strength but does not appear to affect parameters of skeletal muscle endurance or fatigue.
More Related Videos
06:05Advanced Glycation End-Products Sensitize Human Sensory-Like Neuron Cells to Capsaicin-Induced Calcium Influx
Published on: May 2, 2025
09:39Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018